1. Campbell IM, Yuan BO, Robberecht C, Pfundt R, Szafranski P, McEntagart ME, et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am J Hum Genet 2014; 95: 173-182. [
DOI:10.1016/j.ajhg.2014.07.003] [
PMID] [
PMCID]
2. Dai C, Cheng D, Li W, Zeng S, Lu G, Zhang Q. Identification of paternal germline mosaicism by MicroSeq and targeted next‐generation sequencing. Mol Genet Genomic Med 2020; 8: e1394. [
DOI:10.1002/mgg3.1394] [
PMID] [
PMCID]
3. Biesecker LG, Spinner NB. A genomic view of mosaicism and human disease. Nat Rev Genet 2013; 14: 307-320. [
DOI:10.1038/nrg3424] [
PMID]
4. Samuels ME, Friedman JM. Genetic mosaics and the germ line lineage. Genes 2015; 6: 216-237. [
DOI:10.3390/genes6020216] [
PMID] [
PMCID]
5. Mohiuddin M, Kooy RF, Pearson CE. De novo mutations, genetic mosaicism and human disease. Front Genet 2022; 13: 983668. [
DOI:10.3389/fgene.2022.983668] [
PMID] [
PMCID]
6. Amlie‐Wolf L, Bardakjian T, Kopinsky SM, Reis LM, Semina EV, Schneider A. Review of 37 patients with SOX2 pathogenic variants collected by the Anophthalmia/Microphthalmia Clinical Registry and DNA research study. Am J Med Genet A 2022; 188: 187-198. [
DOI:10.1002/ajmg.a.62518] [
PMID] [
PMCID]
7. Watkins KE, Coullon GSL, Bridge H. Language and nonverbal auditory processing in the occipital cortex of individuals who are congenitally blind due to anophthalmia. Neuropsychologia 2022; 173: 108304. [
DOI:10.1016/j.neuropsychologia.2022.108304] [
PMID]
8. Chassaing N, Gilbert‐Dussardier B, Nicot F, Fermeaux V, Encha‐Razavi F, Fiorenza M, et al. Germinal mosaicism and familial recurrence of a SOX2 mutation with highly variable phenotypic expression extending from AEG syndrome to absence of ocular involvement. Am J Med Genet A 2007; 143: 289-291. [
DOI:10.1002/ajmg.a.31524] [
PMID]
9. Williamson KA, Hever AM, Rainger J, Rogers RC, Magee A, Fiedler Z, et al. Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. Hum Mol Genet 2006; 15: 1413-1422.
https://doi.org/10.1093/hmg/ddl127 [
DOI:10.1093/hmg/ddl064] [
PMID]
10. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760. [
DOI:10.1093/bioinformatics/btp324] [
PMID] [
PMCID]
11. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297-1303. [
DOI:10.1101/gr.107524.110] [
PMID] [
PMCID]
12. Wang K, Li M, Hakonarson H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164. [
DOI:10.1093/nar/gkq603] [
PMID] [
PMCID]
13. Dash S, Brastrom LK, Patel SD, Scott CA, Slusarski DC, Lachke SA. The master transcription factor SOX2, mutated in anophthalmia/microphthalmia, is post-transcriptionally regulated by the conserved RNA-binding protein RBM24 in vertebrate eye development. Hum Mol Genet 2020; 29: 591-604. [
DOI:10.1093/hmg/ddz278] [
PMID] [
PMCID]
14. Fantes J, Ragge NK, Lynch S-A, McGill NI, Collin JRO, Howard-Peebles PN, et al. Mutations in SOX2 cause anophthalmia. Nat Genet 2003; 33: 461-463. [
DOI:10.1038/ng1120] [
PMID]
15. Pasmant E, Pacot L. Should we genotype the sperm of fathers from patients with 'de novo' mutations? Eur J Endocrinol 2020; 182: C1-C3. [
DOI:10.1530/EJE-19-0759] [
PMID]
16. Zenteno JC, Perez‐Cano HJ, Aguinaga M. Anophthalmia‐esophageal atresia syndrome caused by an SOX2 gene deletion in monozygotic twin brothers with markedly discordant phenotypes. Am J Med Genet A 2006; 140: 1899-1903. [
DOI:10.1002/ajmg.a.31384] [
PMID]
17. Schneider A, Bardakjian TM, Zhou J, Hughes N, Keep R, Dorsainville D, et al. Familial recurrence of SOX2 anophthalmia syndrome: Phenotypically normal mother with two affected daughters. Am J Med Genet A 2008; 146: 2794-2798. [
DOI:10.1002/ajmg.a.32384] [
PMID] [
PMCID]
18. Morrison D, FitzPatrick D, Hanson I, Williamson K, Van Heyningen V, Fleck B, et al. National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: Investigation of genetic aetiology. J Med Genet 2002; 39: 16-22. [
DOI:10.1136/jmg.39.1.16] [
PMID] [
PMCID]
19. Zlotogora J. Germ line mosaicism. Hum Genet 1998; 102: 381-386. [
DOI:10.1007/s004390050708] [
PMID]
20. Mohrenweiser H, Zingg B. Mosaicism: The embryo as a target for induction of mutations leading to cancer and genetic disease. Environ Mol Mutagen 1995; 25 (Suppl.): 21-29. [
DOI:10.1002/em.2850250606] [
PMID]